{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:45:09Z","timestamp":1790649909621,"version":"4.1.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T00:00:00Z","timestamp":1661731200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T00:00:00Z","timestamp":1661731200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100012095","name":"Scottish Government","doi-asserted-by":"publisher","award":["DDTFRF20"],"award-info":[{"award-number":["DDTFRF20"]}],"id":[{"id":"10.13039\/100012095","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012095","name":"Scottish Government","doi-asserted-by":"publisher","award":["DDTFRF20"],"award-info":[{"award-number":["DDTFRF20"]}],"id":[{"id":"10.13039\/100012095","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012095","name":"Scottish Government","doi-asserted-by":"publisher","award":["DDTFRF20"],"award-info":[{"award-number":["DDTFRF20"]}],"id":[{"id":"10.13039\/100012095","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012095","name":"Scottish Government","doi-asserted-by":"publisher","award":["DDTFRF20"],"award-info":[{"award-number":["DDTFRF20"]}],"id":[{"id":"10.13039\/100012095","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012095","name":"Scottish Government","doi-asserted-by":"publisher","award":["DDTFRF20"],"award-info":[{"award-number":["DDTFRF20"]}],"id":[{"id":"10.13039\/100012095","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012095","name":"Scottish Government","doi-asserted-by":"publisher","award":["DDTFRF20"],"award-info":[{"award-number":["DDTFRF20"]}],"id":[{"id":"10.13039\/100012095","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012095","name":"Scottish Government","doi-asserted-by":"publisher","award":["DDTFRF20"],"award-info":[{"award-number":["DDTFRF20"]}],"id":[{"id":"10.13039\/100012095","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012095","name":"Scottish Government","doi-asserted-by":"publisher","award":["DDTFRF20"],"award-info":[{"award-number":["DDTFRF20"]}],"id":[{"id":"10.13039\/100012095","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>People who use drugs in Scotland are currently experiencing disproportionately high rates of drug-related deaths. Drug consumption rooms (DCRs) are harm reduction services that offer a safe, hygienic environment where pre-obtained drugs can be consumed under supervision. The aim of this research was to explore family member perspectives on DCR implementation in Scotland in order to inform national policy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Scotland-based family members of people who were currently or formerly using drugs were invited to take part in semi-structured interviews to share views on DCRs. An inclusive approach to \u2018family\u2019 was taken, and family members were recruited via local and national networks. A convenience sample of 13 family members were recruited and interviews conducted, audio-recorded, transcribed, and analysed thematically using the Structured Framework Technique.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Family members demonstrated varying levels of understanding regarding the existence, role, and function of DCRs. While some expressed concern that DCRs would not prevent continued drug use, all participants were in favour of DCR implementation due to a belief that DCRs could reduce harm, including saving lives, and facilitate future recovery from drug use. Participants highlighted challenges faced by people who use drugs in accessing treatment\/services that could meet their needs. They identified that accessible and welcoming DCRs led by trusting and non-judgemental staff could help to meet unmet needs, including signposting to other services. Family members viewed DCRs as safe environments and highlighted how the existence of DCRs could reduce the constant worry that they had of risk of harm to their loved ones. Finally, family members emphasised the challenge of stigma associated with drug use. They believed that introduction of DCRs would help to reduce stigma and provide a signal that people who use drugs deserve safety and care.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Reporting the experience and views of family members makes a novel and valuable contribution to ongoing public debates surrounding DCRs. Their views can be used to inform the implementation of DCRs in Scotland but also relate well to the development of wider responses to drug-related harm and reduction of stigma experienced by people who use drugs in Scotland and beyond.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12954-022-00679-5","type":"journal-article","created":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T11:02:55Z","timestamp":1661770975000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["\u2018Why would we not want to keep everybody safe?\u2019 The views of family members of people who use drugs on the implementation of drug consumption rooms in Scotland"],"prefix":"10.1186","volume":"19","author":[{"given":"Tessa","family":"Parkes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracey","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten M. A.","family":"Trayner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry R.","family":"Sumnall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wulf","family":"Livingston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andy","family":"Perkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth","family":"Cairns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josh","family":"Dumbrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Nicholls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,29]]},"reference":[{"key":"679_CR1","unstructured":"United Nations Office on Drugs and Crime. The World Drug Report 2021. Vienna: United Nations; 2021. https:\/\/www.unodc.org\/unodc\/en\/data-and-analysis\/wdr2021.html."},{"key":"679_CR2","unstructured":"UK Parliament. Scottish Affairs Committee: Problem drug use in Scotland inquiry. London: UK Parliament; 2019. https:\/\/publications.parliament.uk\/pa\/cm201919\/cmselect\/cmscotaf\/44\/44.pdf."},{"key":"679_CR3","unstructured":"Scottish Government. Drug Deaths Task Force: Scottish Government; 2019. https:\/\/www.gov.scot\/groups\/drug-deaths-task-force\/."},{"key":"679_CR4","unstructured":"National Records of Scotland. Drug-related deaths in Scotland in 2021. Edinbugh: National Records of Scotland; 2022. https:\/\/www.nrscotland.gov.uk\/files\/statistics\/drug-related-deaths\/20\/drug-related-deaths-20-pub.pdf."},{"issue":"5","key":"679_CR5","doi-asserted-by":"publisher","first-page":"e315","DOI":"10.1016\/S2352-3018(19)30036-0","volume":"6","author":"A McAuley","year":"2019","unstructured":"McAuley A, Palmateer NE, Goldberg DJ, Trayner KMA, Shepherd SJ, Gunson RN, Metcalfe R, Milosevic C, Taylor A, Munro A. Re-emergence of HIV related to injecting drug use despite a comprehensive harm reduction environment: a cross-sectional analysis. Lancet HIV. 2019;6(5):e315\u201324. https:\/\/doi.org\/10.1016\/S2352-3018(19)30036-0.","journal-title":"Lancet HIV"},{"key":"679_CR6","doi-asserted-by":"crossref","unstructured":"Tweed EJ, Rodgers M, Priyadarshi S, Crighton E. \u201cTaking away the chaos\u201d: a health needs assessment for people who inject drugs in public places in Glasgow, Scotland. 2018. https:\/\/www.nhsggc.org.uk\/media\/238302\/nhsggc_health_needs_drug_injectors_full.pdf.","DOI":"10.1186\/s12889-018-5718-9"},{"issue":"5","key":"679_CR7","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s11904-017-0363-y","volume":"14","author":"MC Kennedy","year":"2017","unstructured":"Kennedy MC, Karamouzian M, Kerr T. Public health and public order outcomes associated with supervised drug consumption facilities: a systematic review. Curr HIV\/AIDS Rep. 2017;14(5):161\u201383. https:\/\/doi.org\/10.1007\/s11904-017-0363-y.","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"12","key":"679_CR8","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1111\/add.14747","volume":"114","author":"JP Caulkins","year":"2019","unstructured":"Caulkins JP, Pardo B, Kilmer B. Supervised consumption sites: a nuanced assessment of the causal evidence. Addiction. 2019;114(12):2109\u201315. https:\/\/doi.org\/10.1111\/add.14747.","journal-title":"Addiction"},{"key":"679_CR9","unstructured":"European Monitoring Centre for Drugs and Drug Addiction. Drug consumption rooms: an overview of provision and evidence. Lisbon: European Monitoring Cenrre for Drugs and Drug Addiction 2018. https:\/\/www.emcdda.europa.eu\/system\/files\/publications\/2734\/POD_Drug%20consumption%20rooms.pdf."},{"key":"679_CR10","unstructured":"Drug Policy Alliance. Overdose Prevention Centers 2022 https:\/\/drugpolicy.org\/issues\/supervised-consumption-services."},{"issue":"11","key":"679_CR11","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1503\/cmaj.060863","volume":"175","author":"E Wood","year":"2006","unstructured":"Wood E, Tyndall MW, Montaner JS, Kerr T. Summary of findings from the evaluation of a pilot medically supervised safer injecting facility. CMAJ. 2006;175(11):1399\u2013404. https:\/\/doi.org\/10.1503\/cmaj.060863.","journal-title":"CMAJ"},{"issue":"22","key":"679_CR12","doi-asserted-by":"publisher","first-page":"12073","DOI":"10.3390\/ijerph182212073","volume":"18","author":"F Mercer","year":"2021","unstructured":"Mercer F, Miler JA, Pauly B, Carver H, Hn\u00edzdilov\u00e1 K, Foster R, Parkes T. Peer support and overdose prevention responses: a systematic \u2018state-of-the-art\u2019 review. Int J Environ Res Public Health. 2021;18(22):12073. https:\/\/doi.org\/10.3390\/ijerph182212073.","journal-title":"Int J Environ Res Public Health"},{"key":"679_CR13","unstructured":"European Monitoring Centre for Drugs and Drug Addiction. Alternatives to punishment for drug using offenders. Luxembourg: Publications office of the European Union; 2015. https:\/\/www.emcdda.europa.eu\/system\/files\/publications\/1020\/TDAU14007ENN.pdf."},{"key":"679_CR14","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.drugalcdep.2017.07.016","volume":"180","author":"S Ickowicz","year":"2017","unstructured":"Ickowicz S, Wood E, Dong H, Nguyen P, Small W, Kerr T, Montaner JS, Milloy M-J. Association between public injecting and drug-related harm among HIV-positive people who use injection drugs in a Canadian setting: a longitudinal analysis. Drug Alcohol Depend. 2017;180:33\u20138. https:\/\/doi.org\/10.1016\/j.drugalcdep.2017.07.016.","journal-title":"Drug Alcohol Depend"},{"key":"679_CR15","doi-asserted-by":"publisher","first-page":"102663","DOI":"10.1016\/j.drugpo.2020.102663","volume":"77","author":"KMA Trayner","year":"2020","unstructured":"Trayner KMA, McAuley A, Palmateer NE, Goldberg DJ, Shepherd SJ, Gunson RN, Tweed EJ, Priyadarshi S, Milosevic C, Hutchinson SJ. Increased risk of HIV and other drug-related harms associated with injecting in public places: national bio-behavioural survey of people who inject drugs. Int J Drug Pol. 2020;77:102663. https:\/\/doi.org\/10.1016\/j.drugpo.2020.102663.","journal-title":"Int J Drug Pol"},{"key":"679_CR16","doi-asserted-by":"publisher","first-page":"102731","DOI":"10.1016\/j.drugpo.2020.102731","volume":"90","author":"KMA Trayner","year":"2021","unstructured":"Trayner KMA, Palmateer NE, Hutchinson SJ, Goldberg DJ, Shepherd SJ, Gunson RN, Tweed EJ, Priyadarshi S, Sumnall H, Atkinson A. High willingness to use drug consumption rooms among people who inject drugs in Scotland: findings from a national bio-behavioural survey among people who inject drugs. Int J Drug Pol. 2021;90:102731. https:\/\/doi.org\/10.1016\/j.drugpo.2020.102731.","journal-title":"Int J Drug Pol"},{"issue":"9","key":"679_CR17","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1111\/add.14664","volume":"114","author":"MA Irvine","year":"2019","unstructured":"Irvine MA, Kuo M, Buxton JA, Balshaw R, Otterstatter M, Macdougall L, Milloy MJ, Bharmal A, Henry B, Tyndall M. Modelling the combined impact of interventions in averting deaths during a synthetic-opioid overdose epidemic. Addiction. 2019;114(9):1602\u201313. https:\/\/doi.org\/10.1111\/add.14664.","journal-title":"Addiction"},{"key":"679_CR18","doi-asserted-by":"publisher","first-page":"4639","DOI":"10.2147\/rmhp.s244720","volume":"14","author":"V Tran","year":"2021","unstructured":"Tran V, Reid SE, Roxburgh A, Day CA. Assessing drug consumption rooms and longer term (5 year) impacts on community and clients. Risk Manag Healthc Policy. 2021;14:4639. https:\/\/doi.org\/10.2147\/rmhp.s244720.","journal-title":"Risk Manag Healthc Policy"},{"issue":"9775","key":"679_CR19","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1016\/S0140-6736(10)62353-7","volume":"377","author":"BD Marshall","year":"2011","unstructured":"Marshall BD, Milloy MJ, Wood E, Montaner JS, Kerr T. Reduction in overdose mortality after the opening of North America\u2019s first medically supervised safer injecting facility: a retrospective population-based study. Lancet. 2011;377(9775):1429\u201337. https:\/\/doi.org\/10.1016\/S0140-6736(10)62353-7.","journal-title":"Lancet"},{"issue":"11","key":"679_CR20","doi-asserted-by":"publisher","first-page":"e1002964","DOI":"10.1371\/journal.pmed.1002964","volume":"16","author":"MC Kennedy","year":"2019","unstructured":"Kennedy MC, Hayashi K, Milloy M, Wood E, Kerr T. Supervised injection facility use and all-cause mortality among people who inject drugs in Vancouver, Canada: a cohort study. PLoS Med. 2019;16(11):e1002964. https:\/\/doi.org\/10.1371\/journal.pmed.1002964.","journal-title":"PLoS Med"},{"key":"679_CR21","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-021-07312-4","author":"BH Lambdin","year":"2022","unstructured":"Lambdin BH, Davidson PJ, Browne EN, Suen LW, Wenger LD, Kral AH. Reduced emergency department visits and hospitalisation with use of an unsanctioned safe consumption site for injection drug use in the United States. J Gen Intern Med. 2022. https:\/\/doi.org\/10.1007\/s11606-021-07312-4.","journal-title":"J Gen Intern Med"},{"key":"679_CR22","doi-asserted-by":"crossref","unstructured":"Pardo B, Caulkins JP, Kilmer B. Assessing the Evidence on Supervised Drug Consumption Sites. Santa Monica, CA: RAND Corporation; 2018. https:\/\/www.rand.org\/pubs\/working_papers\/WR1261.html.","DOI":"10.7249\/WR1261"},{"key":"679_CR23","unstructured":"BBC News. Drug consumption rooms are a 'distraction' says UK minister. BBC News. 2020. https:\/\/www.bbc.co.uk\/news\/uk-scotland-51644786."},{"issue":"3","key":"679_CR24","doi-asserted-by":"publisher","first-page":"e196","DOI":"10.1016\/S2468-2667(22)00038-X","volume":"7","author":"A Holland","year":"2022","unstructured":"Holland A, Harris M, Hickman M, Lewer D, Shorter GW, Horsley J, Powell M, Rae M. Overdose prevention centres in the UK. Lancet Public Health. 2022;7(3):e196\u20137. https:\/\/doi.org\/10.1016\/S2468-2667(22)00038-X.","journal-title":"Lancet Public Health"},{"key":"679_CR25","unstructured":"Department of Health and Human Services. Medically supervised injecting room trial - Review panel full report. Melbourne: Centre for Evaluation and Research Evidence; 2020. https:\/\/www.health.vic.gov.au\/publications\/medically-supervised-injecting-room-trial-review-panel-full-report."},{"key":"679_CR26","unstructured":"KPMG. NSW Health further evaluation of the medically supervised injecting centre during its extended trial period (2007\u20132011) final report Sydney: KPMG; 2010. https:\/\/www.health.nsw.gov.au\/aod\/resources\/Documents\/msic-kpmg.pdf."},{"key":"679_CR27","doi-asserted-by":"publisher","first-page":"108521","DOI":"10.1016\/j.drugalcdep.2021.108521","volume":"220","author":"PJ Davidson","year":"2021","unstructured":"Davidson PJ, Lambdin BH, Browne EN, Wenger LD, Kral AH. Impact of an unsanctioned safe consumption site on criminal activity, 2010\u20132019. Drug Alcohol Depend. 2021;220:108521. https:\/\/doi.org\/10.1016\/j.drugalcdep.2021.108521.","journal-title":"Drug Alcohol Depend"},{"key":"679_CR28","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.drugpo.2019.03.010","volume":"68","author":"A Atkinson","year":"2019","unstructured":"Atkinson A, McAuley A, Trayner KMA, Sumnall H. \u2018We are still obsessed by this idea of abstinence\u2019: A critical analysis of UK news media representations of proposals to introduce drug consumption rooms in Glasgow. UK Int J Drug Pol. 2019;68:62\u201374. https:\/\/doi.org\/10.1016\/j.drugpo.2019.03.010.","journal-title":"UK Int J Drug Pol"},{"key":"679_CR29","unstructured":"BBC News. Boris Johnson 'not in favour' of drug consumption rooms. BBC News. 2021. https:\/\/www.bbc.co.uk\/news\/uk-scotland-scotland-politics-58092735."},{"key":"679_CR30","unstructured":"Scottish Government. Rights, Respect and Recovery Action Plan 2019 - 2021. Edinburgh: Scottish Government; 2019. https:\/\/www.gov.scot\/publications\/rights-respect-and-recovery-action-plan\/."},{"key":"679_CR31","unstructured":"Scottish Government. Protecting Scotland's Future: The goverment's programme for Scotland 2019\u20132020. Edinburgh: The Scottish Government; 2019. https:\/\/www.gov.scot\/publications\/protecting-scotlands-future-governments-programme-scotland-2019-20\/."},{"key":"679_CR32","unstructured":"Scottish Government. Rights, Respect and Recovery: alcohol and drug treatment strategy. Edinburgh: Scottish Government; 2018. https:\/\/www.gov.scot\/publications\/rights-respect-recovery\/documents\/."},{"key":"679_CR33","unstructured":"Scottish Drug Deaths Taskforce. Report on Drug Law Reform. Edinburgh: Scottish Drug Death Taskforce; 2021. https:\/\/drugdeathstaskforce.scot\/media\/1248\/drug-law-reform-report-sept-6th-21.pdf."},{"key":"679_CR34","doi-asserted-by":"publisher","unstructured":"Shorter GH, M; McAuley, A; Trayner, KMA; Stevens, A. The UK\u2019s first (unsanctioned) overdose prevention site: A proof of concept evaluation. 2022. https:\/\/doi.org\/10.1016\/j.drugpo.2022.103670.","DOI":"10.1016\/j.drugpo.2022.103670"},{"issue":"2\u20133","key":"679_CR35","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.drugalcdep.2006.10.014","volume":"88","author":"J Ahern","year":"2007","unstructured":"Ahern J, Stuber J, Galea S. Stigma, discrimination and the health of illicit drug users. Drug Alcohol Depend. 2007;88(2\u20133):188\u201396. https:\/\/doi.org\/10.1016\/j.drugalcdep.2006.10.014.","journal-title":"Drug Alcohol Depend"},{"key":"679_CR36","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.drugpo.2018.10.008","volume":"63","author":"CL Barry","year":"2019","unstructured":"Barry CL, Sherman SG, Stone E, Kennedy-Hendricks A, Niederdeppe J, Linden S, McGinty EE. Arguments supporting and opposing legalization of safe consumption sites in the US. Int J Drug Pol. 2019;63:18\u201322. https:\/\/doi.org\/10.1016\/j.drugpo.2018.10.008.","journal-title":"Int J Drug Pol"},{"key":"679_CR37","doi-asserted-by":"publisher","first-page":"102643","DOI":"10.1016\/j.drugpo.2019.102643","volume":"76","author":"SN Bandara","year":"2020","unstructured":"Bandara SN, McGinty EE, Barry CL. Message framing to reduce stigma and increase support for policies to improve the wellbeing of people with prior drug convictions. Int J Drug Pol. 2020;76:102643. https:\/\/doi.org\/10.1016\/j.drugpo.2019.102643.","journal-title":"Int J Drug Pol"},{"issue":"3","key":"679_CR38","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1093\/oxfordjournals.schbul.a007095","volume":"30","author":"PW Corrigan","year":"2004","unstructured":"Corrigan PW, Watson AC. At Issue: Stop the stigma: call mental illness a brain disease. Schizophr Bull. 2004;30(3):477\u20139. https:\/\/doi.org\/10.1093\/oxfordjournals.schbul.a007095.","journal-title":"Schizophr Bull"},{"key":"679_CR39","first-page":"1","volume-title":"Introducing the narrative policy framework","author":"MD Jones","year":"2014","unstructured":"Jones MD, McBeth MK, Shanahan EA. Introducing the narrative policy framework. The science of stories: Springer; 2014. p. 1\u201325."},{"issue":"1","key":"679_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1057\/s41599-019-0232-y","volume":"5","author":"K Oliver","year":"2019","unstructured":"Oliver K, Cairney P. The dos and don\u2019ts of influencing policy: a systematic review of advice to academics. Palgrave Commun. 2019;5(1):1\u201311. https:\/\/doi.org\/10.1057\/s41599-019-0232-y.","journal-title":"Palgrave Commun"},{"issue":"1","key":"679_CR41","doi-asserted-by":"publisher","first-page":"190522","DOI":"10.1098\/rsos.190522","volume":"7","author":"J Reynolds","year":"2020","unstructured":"Reynolds J, Stautz K, Pilling M, van der Linden S, Marteau T. Communicating the effectiveness and ineffectiveness of government policies and their impact on public support: a systematic review with meta-analysis. R Soc Open Sci. 2020;7(1):190522. https:\/\/doi.org\/10.1098\/rsos.190522.","journal-title":"R Soc Open Sci"},{"key":"679_CR42","unstructured":"Echeverria D. At S.F.\u2019s new linkage center, debate intensifies over how best to help drug users. San Francisco Chronicle. 2022. https:\/\/www.sfchronicle.com\/sf\/article\/At-S-F-s-new-linkage-center-debate-16834751.php."},{"key":"679_CR43","unstructured":"Townsend M. The war on drugs killed my daughter. The Observer. 2014. https:\/\/www.theguardian.com\/society\/2014\/jun\/22\/mother-fights-against-war-on-drugs-anne-marie-cockburn-martha-fernback."},{"key":"679_CR44","unstructured":"Anyone's Child. Anyone's Child: families for safer drug control - Stories 2022 https:\/\/anyoneschild.org\/stories\/."},{"key":"679_CR45","unstructured":"Paterson K. Drugs deaths: families remember the loved ones they've lost. The National. 2020. https:\/\/www.thenational.scot\/news\/19481603.drugs-deaths-families-remember-loved-ones-lost\/."},{"key":"679_CR46","unstructured":"Hockaday J. My daughter might still be here if ketamine was legal. Metro. 2021."},{"key":"679_CR47","unstructured":"Transform Drug Policy Foundation. How family testimonies led to Melbourne's first safe injecting room: Anyone's Child; 2021. https:\/\/anyoneschild.org\/2018\/08\/international-overdose-awareness-day\/."},{"key":"679_CR48","unstructured":"Mary J-F. They talk, we die: silent protest at the International Harm Reduction Conference. Volteface. 2017. https:\/\/volteface.me\/talk-die-global-day-action\/."},{"issue":"11","key":"679_CR49","doi-asserted-by":"publisher","first-page":"6575","DOI":"10.3390\/ijerph19116575","volume":"19","author":"J Nicholls","year":"2022","unstructured":"Nicholls J, Livingston W, Perkins A, Cairns B, Foster R, Trayner KMA, Sumnall HR, Price T, Cairney P, Dumbrell J, Parkes T. Drug consumption rooms and public health policy: perspectives of scottish strategic decision-makers. Int J Environ Res Public Health. 2022;19(11):6575. https:\/\/doi.org\/10.3390\/ijerph19116575.","journal-title":"Int J Environ Res Public Health"},{"issue":"6","key":"679_CR50","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","volume":"19","author":"A Tong","year":"2007","unstructured":"Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349\u201357. https:\/\/doi.org\/10.1093\/intqhc\/mzm042.","journal-title":"Int J Qual Health Care"},{"key":"679_CR51","volume-title":"Analysing qualitative data","author":"L Spencer","year":"2002","unstructured":"Spencer L, Ritchie J. Analysing qualitative data. London: Routledge; 2002."},{"issue":"7535","key":"679_CR52","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1136\/bmj.332.7535.220","volume":"332","author":"T Kerr","year":"2006","unstructured":"Kerr T, Stoltz J-A, Tyndall M, Li K, Zhang R, Montaner J, Wood E. Impact of a medically supervised safer injection facility on community drug use patterns: a before and after study. BMJ. 2006;332(7535):220\u20132. https:\/\/doi.org\/10.1136\/bmj.332.7535.220.","journal-title":"BMJ"},{"issue":"12","key":"679_CR53","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1080\/10826084.2017.1293104","volume":"52","author":"M Kirouac","year":"2017","unstructured":"Kirouac M, Witkiewitz K. Identifying, \u201chitting bottom\u201d among individuals with alcohol problems: development and evaluation of the Noteworthy Aspects of Drinking Important to Recovery (NADIR). Subst Use Misuse. 2017;52(12):1602\u201315. https:\/\/doi.org\/10.1080\/10826084.2017.1293104.","journal-title":"Subst Use Misuse"},{"key":"679_CR54","doi-asserted-by":"crossref","unstructured":"Rose. A mother\u2019s story. In: Buxton J, Margo G, Burger L, editors. The impact of global drug policy on women: shifting the needle. Emerald Publishing Limited; 2020. p. 229\u201335.","DOI":"10.1108\/978-1-83982-882-920200031"},{"key":"679_CR55","doi-asserted-by":"publisher","unstructured":"Devaney E. The emergence of the affected adult family member in drug policy discourse: a Foucauldian perspective. Drugs Educ Prev Policy. 2017;24(4):359\u201367. https:\/\/doi.org\/10.1080\/09687637.2017.1340433","DOI":"10.1080\/09687637.2017.1340433"},{"key":"679_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.108078","volume":"213","author":"N Kerman","year":"2020","unstructured":"Kerman N, Manoni-Millar S, Cormier L, Cahill T, Sylvestre J. \u201cIt\u2019s not just injecting drugs\u201d: supervised consumption sites and the social determinants of health. Drug Alcohol Depend. 2020;213: 108078. https:\/\/doi.org\/10.1016\/j.drugalcdep.2020.108078.","journal-title":"Drug Alcohol Depend"},{"key":"679_CR57","unstructured":"Glasgow City Health and Social Care Partnership. Safer drug consumption facilities and heroin-assisted treatment. Glasgow: Glasgow City Health and Social Care Partnership; 2017. https:\/\/www.glasgow.gov.uk\/CHttpHandler.ashx?id=38604&p=0."},{"key":"679_CR58","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/978-3-030-02580-9_5","volume-title":"The language of stigma and addiction","author":"SE Wakeman","year":"2019","unstructured":"Wakeman SE. The language of stigma and addiction. The stigma of addiction: Springer; 2019. p. 71\u201380."},{"issue":"9","key":"679_CR59","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.2105\/AJPH.2018.304588","volume":"108","author":"CL Barry","year":"2018","unstructured":"Barry CL, Sherman SG, McGinty EE. Language matters in combatting the opioid epidemic: safe consumption sites versus overdose prevention sites. Am J Public Health. 2018;108(9):1157\u20139. https:\/\/doi.org\/10.2105\/AJPH.2018.304588.","journal-title":"Am J Public Health"},{"key":"679_CR60","doi-asserted-by":"publisher","DOI":"10.1111\/1745-9133.12566","author":"KM Socia","year":"2021","unstructured":"Socia KM, Stone R, Palacios WR, Cluverius J. Focus on prevention: the public is more supportive of \u201coverdose prevention sites\u201d than they are of \u201csafe injection facilities.\u201d Criminol Public Policy. 2021. https:\/\/doi.org\/10.1111\/1745-9133.12566.","journal-title":"Criminol Public Policy"},{"key":"679_CR61","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0130050","author":"MA Bachhuber","year":"2015","unstructured":"Bachhuber MA, McGinty EE, Kennedy-Hendricks A, Niederdeppe J, Barry CL. Messaging to increase public support for naloxone distribution policies in the United States: results from a randomized survey experiment. PLoS ONE. 2015. https:\/\/doi.org\/10.1371\/journal.pone.0130050.","journal-title":"PLoS ONE"},{"key":"679_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2020.102855","volume":"83","author":"H Sumnall","year":"2020","unstructured":"Sumnall H, Atkinson A, Trayner KMA, Gage S, McAuley A. Effects of messaging on public support for drug consumption rooms in scotland. UK Int J Drug Pol. 2020;83: 102855. https:\/\/doi.org\/10.1016\/j.drugpo.2020.102855.","journal-title":"UK Int J Drug Pol"},{"key":"679_CR63","unstructured":"The Scottish Government. Tackling the stigma of addiction. Edinburgh: The Scottish Government; 2021. https:\/\/www.gov.scot\/news\/tackling-the-stigma-of-addiction\/."},{"key":"679_CR64","unstructured":"Scottish Drugs Forum. SDF and Government launch national campaign to help save lives. Glasgow: Scottish Drugs Forum; 2021. https:\/\/www.sdf.org.uk\/sdf-and-government-launch-national-campaign-to-help-save-lives\/."},{"key":"679_CR65","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-015-0060-3","author":"C Strike","year":"2015","unstructured":"Strike C, Watson TM, Kolla G, Penn R, Bayoumi AM. Ambivalence about supervised injection facilities among community stakeholders. Harm Reduct J. 2015. https:\/\/doi.org\/10.1186\/s12954-015-0060-3.","journal-title":"Harm Reduct J"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-022-00679-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-022-00679-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-022-00679-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,21]],"date-time":"2022-09-21T18:06:16Z","timestamp":1663783576000},"score":1,"resource":{"primary":{"URL":"https:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/s12954-022-00679-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,29]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["679"],"URL":"https:\/\/doi.org\/10.1186\/s12954-022-00679-5","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,29]]},"assertion":[{"value":"25 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The University of Stirling\u2019s General University Ethics Panel (reference: 19\/20 958) provided ethical approval for this study. Secondary ethical approval was also granted by the Glyndwr University in respect of WL\u2019s role given his dual role as a university employee and Figure 8 consultant.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"99"}}